US Patent 7588897 Compositions and methods to detect
Patent 7588897 was granted and assigned to Gen-Probe on September, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+334 characters)
Article
Patent abstract
The disclosed invention includes nucleic acid oligomers that may be used as amplification oligomers, including primers, capture probes for sample preparation, and detection probes for detection of indicator enterococci 23S rRNA sequences in samples by using methods of specific nucleic acid amplification and detection.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07588897 Compositions and methods to detect US Patent 7588897 Compositions and methods to detect
Infobox
Patent Number
0758889700
Patent Number
758889700
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075888970
Date of Patent
September 15, 2009
0Patent Application Number
117473140
Date Filed
May 11, 2007
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075888970
Date of Patent
September 15, 2009
0Patent Application Number
117473140
Date Filed
May 11, 2007
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07588897 Compositions and methods to detect
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07588897
Date of patent
September 15, 2009
Patent application number
11747314
Date Filed
May 11, 2007
Patent primary examiner
Find more entities like US Patent 7588897 Compositions and methods to detect
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.